$14.38
3.98% day before yesterday
NYSE, Aug 22, 10:00 pm CET
ISIN
US29082K1051
Symbol
EMBC

Embecta Stock price

$14.38
+3.69 34.52% 1M
+0.65 4.73% 6M
-6.27 30.36% YTD
+1.19 9.02% 1Y
-18.51 56.28% 3Y
-32.62 69.40% 5Y
-32.62 69.40% 10Y
-32.62 69.40% 20Y
NYSE, Closing price Fri, Aug 22 2025
+0.55 3.98%

Key metrics

Basic
Market capitalization
$841.0m
Enterprise Value
$2.1b
Net debt
$1.3b
Cash
$230.6m
Shares outstanding
58.5m
Valuation (TTM | estimate)
P/E
10.1 | 5.0
P/S
0.8 | 0.8
EV/Sales
1.9 | 1.9
EV/FCF
16.0
P/B
negative
Dividends
DPS
$0.60
Yield 1Y | 5Y
4.2% | 1.9%
Growth 1Y | 5Y
0.0% | -
Payout 1Y | 3Y
44.8% | 20.9%
Increased
0 Years
Financials (TTM | estimate)
Revenue
$1.1b | $1.1b
EBITDA
$353.1m | $407.2m
EBIT
$316.0m | $336.8m
Net Income
$83.6m | $168.2m
Free Cash Flow
$132.3m
Growth (TTM | estimate)
Revenue
-1.5% | -1.6%
EBITDA
53.0% | 26.8%
EBIT
38.5% | 18.2%
Net Income
19.9% | 114.8%
Free Cash Flow
865.7%
Margin (TTM | estimate)
Gross
64.0%
EBITDA
32.0% | 36.9%
EBIT
28.7%
Net
7.6% | 15.2%
Free Cash Flow
12.0%
Financial Health
Equity Ratio
-57.4%
Return on Equity
-10.6%
ROCE
35.8%
ROIC
31.4%
Debt/Equity
-2.2
More
EPS
$1.4
FCF per Share
$2.3
Short interest
7.5%
Employees
2k
Rev per Employee
$530.0k
Show more

Is Embecta a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,015 stocks worldwide.

Embecta Stock Analysis

Unlock Scores for Free

Analyst Opinions

9 Analysts have issued a Embecta forecast:

1x Buy
11%
4x Hold
44%
4x Sell
44%

Analyst Opinions

9 Analysts have issued a Embecta forecast:

Buy
11%
Hold
44%
Sell
44%

Financial data from Embecta

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
1,103 1,103
1% 1%
100%
- Direct Costs 398 398
6% 6%
36%
705 705
5% 5%
64%
- Selling and Administrative Expenses 342 342
6% 6%
31%
- Research and Development Expense 37 37
55% 55%
3%
353 353
53% 53%
32%
- Depreciation and Amortization 37 37
1,327% 1,327%
3%
EBIT (Operating Income) EBIT 316 316
38% 38%
29%
Net Profit 84 84
20% 20%
8%

In millions USD.

Don't miss a Thing! We will send you all news about Embecta directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Embecta Stock News

Neutral
Seeking Alpha
16 days ago
Embecta Corp. (NASDAQ:EMBC ) Q3 2025 Earnings Conference Call August 8, 2025 8:00 AM ET Company Participants Devdatt Kurdikar - President, CEO & Director Jacob P. Elguicze - Senior VP & CFO Pravesh Khandelwal - VP & Head of Investor Relations Conference Call Participants Anthony Charles Petrone - Mizuho Securities USA LLC, Research Division Gracia Leydon Mahoney - BofA Securities, Research Divi...
Neutral
GlobeNewsWire
16 days ago
PARSIPPANY, N.J., Aug. 08, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta” or the "Company") (Nasdaq: EMBC), a global diabetes care company, today reported financial results for the three and nine month periods ended June 30, 2025.
Neutral
GlobeNewsWire
16 days ago
PARSIPPANY, N.J., Aug. 08, 2025 (GLOBE NEWSWIRE) -- The Board of Directors of Embecta Corp. (“embecta”) (Nasdaq: EMBC) has declared a quarterly cash dividend of $0.15 for each issued and outstanding share of the Company's common stock. The dividend is payable on September 15, 2025 to stockholders of record at the close of business on August 29, 2025.
More Embecta News

Company Profile

Embecta Corp. engages in the provision of medical devices used in the treatment of diabetes. Its products include pen needles, syringes, and safety devices complemented by a digital application. The company was founded in 1924 and is headquartered in Parsippany, NJ.

Head office United States
CEO Devdatt Kurdikar
Employees 2,100
Founded 1924
Website www.embecta.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today